These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6026493)

  • 21. The discriminant diagnostic power of liver function tests in hepatic cirrhosis.
    Serra MA; Rodrigo JM; Guix J; Montes F; Wassel A; Aparisi L; Olmo JA; Bixquert M
    Acta Med Port; 1981; 3(1):3-10. PubMed ID: 7304266
    [No Abstract]   [Full Text] [Related]  

  • 22. [Contribution to the study of liver changes during aging. Changes in the kinetics of bromsulphalein].
    Skaunic V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1967; 10(4):Suppl:355-82. PubMed ID: 5243433
    [No Abstract]   [Full Text] [Related]  

  • 23. Functional deficits in the isolated perfused pig liver.
    Elmslie RG; Rao MM; Howe LA; Hall P
    Surg Gynecol Obstet; 1971 Jul; 133(1):89-92. PubMed ID: 5091830
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatic glycogenosis: abnormal liver function tests in Type 1 diabetes.
    Cuthbertson DJ; Brennan G; Walsh S; Henry E
    Diabet Med; 2007 Mar; 24(3):322-3. PubMed ID: 17305792
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of age and excessive body weight on the distribution and metabolism of bromsulphalein.
    Freston JW; Englert E
    Clin Sci; 1967 Oct; 33(2):301-12. PubMed ID: 6058429
    [No Abstract]   [Full Text] [Related]  

  • 26. The enterohepatic circulation of sulfobromophthalein sodium. Results of a study on 24 patients.
    Deshpande SY
    Med Ann Dist Columbia; 1968 Mar; 37(3):164-6. PubMed ID: 5238778
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinico-statistical evaluation of the simultaneous clearance of sulfobromophthalein and galactose in chronic liver diseases].
    Rossi L; Innocenti P; Milani A; Bombardieri G
    Quad Sclavo Diagn; 1983 Jun; 19(2):271-84. PubMed ID: 6676775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of ethylestrenol and lynestrenol on the bromsulphalein metabolism in man].
    Elewaut A; Barbier F; Versieck J
    Rev Int Hepatol; 1965; 15(6):1045-64. PubMed ID: 5322737
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of repeated oral administration on taurocholate on hepatic excretory function in the rat.
    Watkins JB; Klaassen CD
    J Pharmacol Exp Ther; 1981 Jul; 218(1):182-7. PubMed ID: 7241377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improvement of the semilogarithmic diagram showing the slopes of sulfobromophthalein clearance; attempted correlative interpretation of so-called hepatic fixation and biliary elimination clearances].
    Toulet J; Davezac JF; Lunel J; Albot G
    Sem Hop; 1965 Jun; 41(31):1865-86. PubMed ID: 4284871
    [No Abstract]   [Full Text] [Related]  

  • 31. [Liver function in adipose patients under hunger therapy].
    Hasik J; Tyc M
    Dtsch Z Verdau Stoffwechselkr; 1972; 32(1):101-3. PubMed ID: 4655066
    [No Abstract]   [Full Text] [Related]  

  • 32. Impairment of liver function resulting from shock in patients with severe fractures.
    Koskinen EV; Julkunen H; Honkonen K
    Ann Chir Gynaecol Fenn; 1967; 56(3):296-303. PubMed ID: 5591932
    [No Abstract]   [Full Text] [Related]  

  • 33. [Intolerance reactions to bromosulphalein in hepatic diagnostics].
    Robert L; Rizzo F
    Arch Maragliano Patol Clin; 1970; 26(4):259-72. PubMed ID: 5536702
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluating hepatic function. II. Dye excretion studies using sulfobromophthalein (BSP). Number twenty-nine in a series.
    Morgan HC
    Vet Med Small Anim Clin; 1969 Apr; 64(4):338-41. PubMed ID: 5191734
    [No Abstract]   [Full Text] [Related]  

  • 35. Narcotic effects on hepatic disposition of sulfobromophthalein in rats.
    Hurwitz A; Fischer HR
    J Pharmacol Exp Ther; 1983 Oct; 227(1):68-72. PubMed ID: 6620173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Age dependence of bromsulphalein retention].
    Schwager A; Brügmann E; Maass M
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(2):85-7. PubMed ID: 4788959
    [No Abstract]   [Full Text] [Related]  

  • 37. [The kinesis of bromosulfalein (quantitative determination of hepatic function and cholestasis)].
    Tura S; Dal Monte PR; Pieragnoli E
    Fegato; 1965 Mar; 11(1):28-52. PubMed ID: 5832750
    [No Abstract]   [Full Text] [Related]  

  • 38. Fractional clearance of bromosulfonephthalein and metabolic clearance of antipyrine. Correlative study in liver diseases.
    Couet C; Brissot P; Messner M; Delamaire D; Gie S; Bourel M
    Ann Gastroenterol Hepatol (Paris); 1984; 20(1):1-6. PubMed ID: 6529154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic function test--2. Bilirubin metabolism, bromsulphalein (BSP) excretion test.
    Goldston RT; Wilkes RD; Seybold IM
    Vet Med Small Anim Clin; 1981 Jun; 76(6):795-7. PubMed ID: 6911907
    [No Abstract]   [Full Text] [Related]  

  • 40. [Excretory function of the liver after sustained terminal states].
    Shapiro VM
    Patol Fiziol Eksp Ter; 1967; 11(4):40-3. PubMed ID: 5260025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.